Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about ALPMF

Recent news which mentions ALPMF

JP Morgan Cut Apellis' Price Forecasts, Cites Longer Peak Sales Timing For Syfovre

March 18, 2025

Pfizer/Astellas Tout Encouraging Data From Keytruda Combo Regime In Urothelial Cancer Showing 49% Reduction In Death Risk Vs. Chemo

February 11, 2025

Elevation Oncology: Promising Cancer Therapies Earn Analyst Praise

January 03, 2025

Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact

December 31, 2024

Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch

October 16, 2024

Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data

August 05, 2024

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval

May 17, 2024

Merck's Best Selling Cancer Drug Meets One Goal In Late-Stage Bladder Cancer Study

October 05, 2023

Why Is Seagen Stock Trading Higher Today?

September 22, 2023

What's Going On With Neurology Focused Taysha Gene Therapies Stock Today?

September 20, 2023

Why Shares of Adaptive Biotechnologies Jumped This Week

June 16, 2023

Astellas Pharma Licenses Promising Gene Therapy KT430 from Kate Therapeutics Amidst Clinical Hurdles

June 08, 2023

Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?

May 30, 2023

Google Launches Tools To Detect Fake Images, Apple May Encounter Delays In iPhone 15 Production, Shake Shack Sees Activist Investor Proxy Fight: Today's Top Stories

May 15, 2023

Astellas' Menopause Drug Sores FDA Approval, After Regulatory Setback

May 15, 2023

Pfizer, Astellas' Xtandi Combo Therapy Cuts Risk Of Metastasis, Death In Prostate Cancer By 58%

May 01, 2023

Astellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration'

May 01, 2023

FDA Approves Merck's Keytruda Combined With Seagen/Astellas's Padcev For Advanced Urothelial Cancer

April 04, 2023

AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners

March 28, 2023

Japanese Government Urges China To Release Astellas Pharma's Employee

March 27, 2023

Pfizer, Astellas Tout Positive Xtandi Data To Potentially Expand Label For The Prostate Cancer Drug

March 17, 2023

Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts

January 31, 2023

Sandoz Acquires Antifungal Agent From Astellas, Reinforcing Hospital Offering

January 24, 2023

Astellas Pharma Invests $50M To Support Taysha's Gene Therapy Programs

October 25, 2022

Astellas' Menopause Drug Under FDA Review

August 18, 2022

Seagen's Bladder Cancer Trial Data Meets Expectation, Analysts Say

July 26, 2022

Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate

July 26, 2022

Seagen Shares Jump On Positive Data From Urothelial Cancer Trial

July 26, 2022

The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives

June 28, 2022

Sutro Biopharma Stock Surges On Cancer Treatment Pact

June 28, 2022

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.